NEW YORK (GenomeWeb News) – Accelerate Diagnostics said after the close of the market on Monday that it has commenced a $45 million rights offering to fund the firm's product commercialization efforts.

The Tucson, Ariz.-based company is distributing at no charge to the holders of its common stock as of 5:00 PM EDT, March 14, 2014, .063921 non-transferable subscription rights for each share of stock owned.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The genome of the carnivorous bladderwort is smaller than many other plant genomes, but it still holds on to important genes.

In PLOS this week: new gene linked to ocular coloboma, new statistical model for interrogating gene expression networks, and more.

With a new collection, PLOS highlights negative results it has published.

A pair of researchers examines political leanings and views on genomics, finding more of a role for optimism and pessimism in people's views.